Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.3.5 (
5'-nucleotidase
)
3,167
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
It was found that mitochondria from human placenta exhibited an ADPase activity with the following characteristics. The enzyme responsible for this activity was associated with the inner mitochondrial membrane. It was not released by treatment of the submitochondrial particles with solutions of high ionic strength. Maximal ADP hydrolysis was reached at pH 8. Specific inhibitors for alkaline phosphatase (L-phenylalanine), myokinase (P1,P5-di(adenosine-5')pentaphosphate), or
5'-nucleotidase
(concanavalin A) did not decrease ADP hydrolysis. ATP synthesis from ADP by myokinase was about 13 nmol/mg/min, whereas ADP hydrolysis reached values around 500 to 550 nmol/mg/min, indicating that a myokinase-H+ATPase combination could not account for the observed rates of ADP hydrolysis. The activity was stimulated by Mg2+, but high concentrations of this cation produced inhibition. High ADP concentrations did not inhibit ADPase activity. Kinetic measurements of the activity in the submitochondrial particles showed that the true substrate was ADP-Mg. The kinetic studies showed V(app) values of 476 and 270 nmol/mg/min, and Kmapp values of 416 and 8.7 microM.
Placenta
PMID:Subcellular localization and properties of adenosine diphosphatase in human placenta. 147 Jun 6
Using density gradient centrifugation, human trophoblastic cells were enriched from mixed cell populations of enzymatically dispersed first- and third-trimester placentae. Over 95 per cent of the cells recovered were of epithelial (i.e., trophoblastic) origin, as evidenced by their cytokeratin intermediate filament positivity and vimentin negativity, examined using indirect immunofluorescence, and also by their high content of human chorionic gonadotrophin. The activities of key enzymes involved in purine degradation and re-utilization (
5'-nucleotidase
; AMP-deaminase; hypoxanthine phosphoribosyltransferase (HPRT); xanthine dehydrogenase/oxidase) as well as the total activity of alkaline phosphatase were measured in the trophoblastic cells. A six-fold increase in the trophoblastic alkaline phosphatase activity was noted between the first and third trimester. A 40 per cent decrease was noted in the activity of
5'-nucleotidase
, which, on the basis of kinetic properties, appears to have a dominant role in the dephosphorylation of placental nucleoside-5'-monophosphates. The trophoblastic activities of AMP-deaminase, HPRT, and xanthine dehydrogenase/oxidase did not change as a function of the gestational age. In view of the relative activities of the latter two enzymes, hypoxanthine formed in the trophoblast appears more likely to be re-utilized than degraded to uric acid.
Placenta
PMID:Activities of key enzymes of purine degradation and re-utilization in human trophoblastic cells. 283 9
A simple procedure is described for the further purification of placental microvillus preparations. Based on previously published methods for the isolation of microvilli from other tissues, it depends on the preferential aggregation of containing structures by Mg2+. In the purified microvillus preparation, the two placental microvillar marker enzymes, alkaline phosphatase and
5'-nucleotidase
, were enriched 24-fold and were obtained in 5 per cent yield. Five other microvilla enzymes were also further enriched by the Mg2+-treatment. Marker enzymes for other subcellular components showed that this treatment completely removed contamination by mitochondria and endoplasmic reticulum and contamination by lysosomes was decreased three-fold. (Na+ + K+)-activated ATPase was depleted by the Mg2+-treatment as was beta2-microglobulin.
Placenta
PMID:An improved method for the preparation of human placental syncytiotrophoblast microvilli. 625 28
Subcellular fractionation of human term placenta showed that the highest relative specific activity of
5'-nucleotidase
and alkaline phosphatase resided in the microsomal fraction; of the total
5'-nucleotidase
activity present, 7 per cent was in the cytosol. 5'-Nucleotidase was reproducibly purified over 500-fold in 17 per cent yield from the insoluble component of homogenates of term placenta to give a single major glycoprotein with two minor inactive protein contaminants. Purified placental
5'-nucleotidase
was free from non-specific or alkaline phosphatase, hydrolysed 12 to 22 mumol AMP/min/mg of protein at 30 degrees C, and was activated up to fivefold by Triton X-100. AMP, Km 5 to 7 microM, was the preferred substrate. The Arrhenius plot was biphasic, with activation energies of 21.7 and 49.7 kJ/mol above and below 36 degrees C, the region of the transition temperature. Nucleoside di- and triphosphates inhibited competitively; the most potent inhibitors were ADP and adenosine 5'-methylenediphosphonate, Ki slope 90 nm and 6 nm, respectively. Lectins inhibited the enzyme; concanavalin A caused time-dependent inactivation reversible by alpha-methyl-D-mannoside. EDTA inactivated the enzyme; partial reactivation was achieved with divalent cations. The pH optimum was 7.2 to 7.3; Mg2+ produced a second alkaline pH optimum. The properties of placental
5'-nucleotidase
are those of an intrinsic membrane protein and, in general, resemble properties of the several 'ecto'-5'-nucleotidases which have been purified from other tissues, although certain differences in kinetic properties of the placental enzyme are apparent.
Placenta
PMID:Human placental 5'-nucleotidase: purification and properties. 632 73